© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Alpha Teknova, Inc. (TKNO) stock surged +4.56%, trading at $7.79 on NASDAQ, up from the previous close of $7.45. The stock opened at $7.34, fluctuating between $7.31 and $7.92 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 7.39 | 7.92 | 7.24 | 7.79 | 501.71K |
| Sep 17, 2026 | 7.40 | 7.56 | 7.00 | 7.45 | 310.07K |
| Sep 16, 2026 | 6.96 | 7.17 | 6.82 | 7.11 | 171.17K |
| Sep 15, 2026 | 6.79 | 6.93 | 6.65 | 6.90 | 117.17K |
| Sep 14, 2026 | 6.72 | 6.86 | 6.33 | 6.82 | 237.93K |
| Sep 11, 2026 | 7.01 | 7.07 | 6.67 | 6.71 | 100K |
| Sep 10, 2026 | 6.86 | 6.93 | 6.71 | 6.91 | 88.12K |
| Sep 09, 2026 | 6.85 | 7.20 | 6.77 | 6.96 | 183.39K |
| Sep 08, 2026 | 6.84 | 7.07 | 6.78 | 6.88 | 134.75K |
| Sep 04, 2026 | 7.15 | 7.15 | 6.82 | 6.92 | 142.91K |
| Sep 03, 2026 | 7.52 | 7.52 | 6.91 | 7.24 | 163.57K |
| Sep 02, 2026 | 7.15 | 7.64 | 7.15 | 7.43 | 217.63K |
| Sep 01, 2026 | 7.16 | 7.22 | 6.93 | 7.08 | 85.83K |
| Aug 31, 2026 | 7.15 | 7.24 | 7.06 | 7.18 | 121.31K |
| Aug 28, 2026 | 7.30 | 7.35 | 7.01 | 7.12 | 114.56K |
| Aug 27, 2026 | 7.20 | 7.48 | 7.19 | 7.31 | 174.03K |
| Aug 26, 2026 | 7.38 | 7.50 | 7.08 | 7.22 | 190.13K |
| Aug 25, 2026 | 7.34 | 7.51 | 7.21 | 7.46 | 162.17K |
| Aug 24, 2026 | 7.38 | 7.38 | 7.05 | 7.34 | 180.06K |
| Aug 21, 2026 | 7.08 | 7.45 | 6.85 | 7.36 | 220.46K |
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
| Employees | 158 |
| Beta | 0.73 |
| Sales or Revenue | $36.68M |
| 5Y Sales Change% | 0.498% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |